Huge public companies still prospered this past year despite wild swings between market uncertainty and volatility, punctuated by unexpected political outcomes.
The 2017 Global 2000 is bigger and more valuable in the aggregate than last year’s list, with higher sales, profits, assets and market values. The list as a whole is significantly more valuable from the year prior, with aggregate market capitalization up 10%. Here’s how we crunched the numbers.
Despite slowing GDP figures, China and the U.S., whose companies make up more than 40% of the list, continue to dominate the top 10 list with financial giants including #1 Industrial and Commercial Bank of China (ICBC) and #4 JPMorgan Chase. China’s two-year stronghold of the top 3 spots was disrupted this year with Warren Buffett’s Berkshire Hathaway snagging the third spot, another signal that U.S. companies didn’t suffer terribly from market uncertainty that defined the year, as Berkshire owns many other American staple stocks.
Hot Warren Buffett Stocks To Invest In Right Now: MarketAxess Holdings, Inc.(MKTX)
- [By Joe Tenebruso]
MarketAxessHoldings (NASDAQ:MKTX)reported first-quarter results on April 26. The electronic trading platform is enjoying strong gains in revenue and profits as it continues to take share of the massive global fixed-income market.
- [By ]
This is why I’m bullish on a company that promises to mitigate the liquidity issues facing the bond market. The company is MarketAxess (Nasdaq: MKTX).
Hot Warren Buffett Stocks To Invest In Right Now: Radient Technologies (RTI)
- [By Bryan Murphy]
It’s been a long time in the coming, but there’s no denying the tipping point has been reached — cannabinoids are the foundation for a whole new kind of medicine. And, the work-to-date turning cannabis into pharmaceuticals has been very encouraging.
Problem: While the premise of cannabinoids as drugs has been validated, the science of creating large quantities of pure cannabinoids remains more ineffective than effective. Radient Technologies Inc (CVE:RTI) is about the change that, leveraging a means of extracting a lot of cannabinoid material from a source, and ensuring the highest-level of purity and quality.
Radient Technologies manufactures natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics. Using a proprietary, patented technology, Radient’s products are superior in quality and purity while manufactured at a significantly lower cost than other methods thanks to superior yields and efficiency.
To fully appreciate the science Radient has developed, however, one must understand the alternative methods currently employed.
With current approaches to create ingredients from an appropriate source, the material with the target compound or molecule in it is soaked in a solvent, heated, and then over the course of several hours the desired ingredient diffuses into the solvent. After filtration, drying, and other processing, that ingredient is finally isolated and then collected.
It works, but it’s far from ideal. Aside from the fact that this technique doesn’t work very well at large scale, yields are relatively low. Worse, many undesirable components can still be found in the extract, lowering the quality and purity of the ingredient.
Radient Technologies uses an ingredient-extraction process called microwave assisted processing, or “MAP,” for short.
Using its patented MAP process, Radient is able to selectiv
- [By Matthew Briar]
There’s an old business adage…. it’s not so much what you know, but who you know. If that’ s truly the case (and it is), then shareholders in Radient Technologies Inc (CVE:RTI) should be elated. The newest member of the Board of Directors that not already knows a lot of the right people, but has pretty much done all of things Radient would like to accomplish in the near future. That is, he was on the board for another ingredient and chemical company that was eventually acquired, but he also holds a masters degree in engineering. He can do it all, understanding the art and science of the business.
It’s yet another reason for RTI investors to be enthused.
Radient Technologies isn’t exactly a new company, but it’s relative notoriety is a fairly new phenomenon.
The organization, in simplest terms, has developed an ingredient-extraction process called microwave assisted processing, or “MAP,” for short. As the name implies, the use of radio microwaves helps the extraction process along.
Using its patented MAP process, Radient is able to selectively deposit microwave energy into a biomass (source material) and heat the target elements while leaving other materials in the mix unaltered. The near-instantaneous “in-core” heating that occurs creates pressure which drives out the targeting ingredient or component much faster than more conventional extraction methods. In fact, the pressure-driven process outperforms the conventional extraction on pretty much every front. That is, the technique reduces the extraction time from hours to minutes, delivers a higher active ingredient purity, increases the recovery of actives from often scarce biomass, and uses much less solvent and energy than the more typical approach.
The technique can, and already has, created natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics.
- [By Jim Robertson]
Small cap Radient Technologies (CVE: RTI) is focused on extracting, isolating and purifying food/nutraceutical ingredients (colourings, flavourings, preservatives etc) and pharmaceutical raw materials from its20,000 square foot manufacturing plant in Edmonton, Alberta. The Companyworks with global brands across a range of industries (including Food and Beverage, Nutrition and Supplements, Pharmaceuticals, Personal Care and Cosmetics and Biofuel) andengageswithits clients in three distinct phases:
- [By Matthew Briar]
At first glance, a new set of rules from the Drug Enforcement Agency unveiled in the middle of December looked like it posed a problem for cannabis-newcomer Radient Technologies Inc (CVE:RTI). By assigning a controlled substances code number to ‘marijuana extract,’ simultaneously distinguishing (and acknowledging the differences of marijuana, hemp and their derivatives as Schedule I substances. As the ruling’s language explained, “This code number will allow DEA and DEA-registered entities to track quantities of this material separately from quantities of marihuana. This, in turn, will aid in complying with relevant treaty provisions.”
It presents something of an uncertainty, as it was not clear of the DEA also meant hemp and cannabis extracts when it used the term ‘marijuana extract.’ After all, the Drug Enforcement Agency has thus far done a poor job of distinguishing between hemp and marijuana, but has generally erred on the side of grouping everything as marijuana…. even if it didn’t cause a ‘high,’ and even if it did provide a medical benefit. If that was indeed the case, Radient Technologies may well be a non-starter in its quest to get into the cannabis business.
No need to worry. Though it took weeks to get some much-needed clarification, the DEA has finally explained what it was saying two months ago. Indeed, the new ruling may actually help the medical marijuana — cannabis — along. DEA spokesman Russ Baer said in an e-mail to The Cannabist, “(The rule change) recognizes that there is a potential medical benefit to some of the cannabinoids.”
Some still worry the wording of the law essentially, even if unintentionally, puts cannabinoids (or CBD) under the purveyance of the DEA; it’s currently not. Even so, if nothing else the ruling has the government moving towards clarity, after acknowledging CBD — the healthy version of the cannabis, and not the one that gets you high — has medical value. The next step is clarifying ho
Hot Warren Buffett Stocks To Invest In Right Now: Houghton Mifflin Harcourt Company(HMHC)
- [By Peter Graham]
A long term performance chart shows Chegg Inc finallymovingabove IPO levels while potential performance benchmarks such as Houghton Mifflin Harcourt Co (NASDAQ: HMHC) and Barnes & Noble Education Inc (NYSE: BNED), a spin off from Barnes & Noble, Inc (NYSE: BKS), have seen their performance slip:
- [By Peter Graham]
A long term performance chart shows shares of Barnes & Noble Education and global learning stockHoughton Mifflin Harcourt Co (NASDAQ: HMHC)underperforming while Barnes & Noble is back to breakeven levels and textbook stock Chegg Inc (NYSE: CHGG) has taken off: